Measuring Adiposity in Patients: The Utility of Body Mass Index (BMI), Percent Body Fat, and LeptinNirav R. Shah, Eric R. Braverman|PLoS ONE|2012Cited by 551
<i>In Silico</i> Pharmacogenomic Assessment of Glucagon-like Peptide-1 (GLP1) Agonists and the Genetic Addiction Risk Score (GARS) Related Pathways: Implications for Suicidal Ideation and Substance Use DisorderAlireza Sharafshah, Kenneth Blum, Mark S. Gold et al.|Current Neuropharmacology|2025Cited by 9